Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Cancers
|
January 11, 2025
A Narrative Review of the Assessment and Treatment of Physical Impairments Commonly Seen in Sarcoma Cancer Survivors Using a Rehabilitative Approach
Adrian Cristian, Nandita Keole, Romer Orada, et al.
Journal of Patient-Centered Research and Reviews
|
February 1, 2020
Surgeons' Views on Shared Decision-Making
Suraj Kannan, Jayhyun Seo, Kevin R Riggs, et al.
Journal of the American Academy of Dermatology
|
May 27, 2023
Underuse of sentinel lymph node biopsy for early-stage melanoma
Ahmad Rajeh, Guihong Wan, Katie Roster, et al.
Scientific Reports
|
September 23, 2018
Biomechanical interplay between anisotropic re-organization of cells and the surrounding matrix underlies transition to invasive cancer spread
Deok-Ho Kim, Andrew J Ewald, JinSeok Park, et al.
Journal for Immunotherapy of Cancer
|
June 15, 2022
Real-world incidence and impact of pneumonitis in patients with lung cancer treated with immune checkpoint inhibitors: a multi-institutional cohort study
Bruce C Tiu, Leyre Zubiri, James Iheke, et al.
JAMA Dermatology
|
January 12, 2022
Association of Cutaneous Immune-Related Adverse Events With Increased Survival in Patients Treated With Anti-Programmed Cell Death 1 and Anti-Programmed Cell Death Ligand 1 Therapy
Kimberly Tang, Jayhyun Seo, Bruce C Tiu, et al.
The Lancet. Oncology
|
July 18, 2024
Multi-organ immune-related adverse events from immune checkpoint inhibitors and their downstream implications: a retrospective multicohort study
Guihong Wan, Wenxin Chen, Sara Khattab, et al.
Medrxiv : the Preprint Server for Health Sciences
|
January 30, 2023
Cutaneous immune-related adverse events are associated with longer overall survival in advanced cancer patients on immune checkpoint inhibitors: a multi-institutional cohort study
Shijia Zhang, Kimberly Tang, Guihong Wan, et al.
Journal of the American Academy of Dermatology
|
February 3, 2023
Cutaneous immune-related adverse events are associated with longer overall survival in advanced cancer patients on immune checkpoint inhibitors: A multi-institutional cohort study
Shijia Zhang, Kimberly Tang, Guihong Wan, et al.
Journal of the American Academy of Dermatology
|
February 24, 2023
Influence of melanoma type on incidence and downstream implications of cutaneous immune-related adverse events in the setting of immune checkpoint inhibitor therapy
Nga Nguyen, Guihong Wan, Pearl Ugwu-Dike, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Cancers
|
January 11, 2025
A Narrative Review of the Assessment and Treatment of Physical Impairments Commonly Seen in Sarcoma Cancer Survivors Using a Rehabilitative Approach
Adrian Cristian, Nandita Keole, Romer Orada, et al.
Journal of Patient-Centered Research and Reviews
|
February 1, 2020
Surgeons' Views on Shared Decision-Making
Suraj Kannan, Jayhyun Seo, Kevin R Riggs, et al.
Journal of the American Academy of Dermatology
|
May 27, 2023
Underuse of sentinel lymph node biopsy for early-stage melanoma
Ahmad Rajeh, Guihong Wan, Katie Roster, et al.
Scientific Reports
|
September 23, 2018
Biomechanical interplay between anisotropic re-organization of cells and the surrounding matrix underlies transition to invasive cancer spread
Deok-Ho Kim, Andrew J Ewald, JinSeok Park, et al.
Journal for Immunotherapy of Cancer
|
June 15, 2022
Real-world incidence and impact of pneumonitis in patients with lung cancer treated with immune checkpoint inhibitors: a multi-institutional cohort study
Bruce C Tiu, Leyre Zubiri, James Iheke, et al.
JAMA Dermatology
|
January 12, 2022
Association of Cutaneous Immune-Related Adverse Events With Increased Survival in Patients Treated With Anti-Programmed Cell Death 1 and Anti-Programmed Cell Death Ligand 1 Therapy
Kimberly Tang, Jayhyun Seo, Bruce C Tiu, et al.
The Lancet. Oncology
|
July 18, 2024
Multi-organ immune-related adverse events from immune checkpoint inhibitors and their downstream implications: a retrospective multicohort study
Guihong Wan, Wenxin Chen, Sara Khattab, et al.
Medrxiv : the Preprint Server for Health Sciences
|
January 30, 2023
Cutaneous immune-related adverse events are associated with longer overall survival in advanced cancer patients on immune checkpoint inhibitors: a multi-institutional cohort study
Shijia Zhang, Kimberly Tang, Guihong Wan, et al.
Journal of the American Academy of Dermatology
|
February 3, 2023
Cutaneous immune-related adverse events are associated with longer overall survival in advanced cancer patients on immune checkpoint inhibitors: A multi-institutional cohort study
Shijia Zhang, Kimberly Tang, Guihong Wan, et al.
Journal of the American Academy of Dermatology
|
February 24, 2023
Influence of melanoma type on incidence and downstream implications of cutaneous immune-related adverse events in the setting of immune checkpoint inhibitor therapy
Nga Nguyen, Guihong Wan, Pearl Ugwu-Dike, et al.
Page
of 1